Supreme Court Rejects Lawsuit Against California Mint Cigarette Ban

Regulations by 2FIRSTS.ai
Jan.09.2024
Supreme Court Rejects Lawsuit Against California Mint Cigarette Ban
The US Supreme Court rejects Reynolds Tobacco's lawsuit against California's mint flavored cigarette ban, while Biden's proposed nationwide ban remains uncertain.

According to an article published on January 8th by DailyMail, the Supreme Court of the United States has rejected the lawsuit filed by Reynolds Tobacco against California's ban on menthol cigarettes. Meanwhile, President Biden's proposed nationwide ban on flavored cigarettes faces uncertain circumstances.

 

On January 8th, the Supreme Court declined to review a case brought by Reynolds Tobacco, which questioned the ban on flavored cigarettes imposed by the Democratic-led state of California.

 

In 2020, Governor Gavin Newsom, a Democratic governor, signed the bill in an attempt to curb the use of e-cigarettes and flavored tobacco among teenagers and young Americans. California became the second state in the country, after Massachusetts, to implement such a ban.

 

Last month, the Biden administration postponed its plans to implement a nationwide ban on menthol cigarettes, as it faced political opposition and warnings that such action might anger the black voters who are gradually distancing themselves from the President.

 

Recent series of opinion polls indicate that President Biden's proposed ban on menthol cigarettes could potentially have "unintended consequences" on his 2024 re-election prospects.

 

According to the latest survey obtained by the Daily Mail, over 60% of the national voters believe that the ban on menthol cigarettes will disproportionately harm minority communities, including 63% of Democrats.

 

The government is expected to announce in March that these regulations will finally come into effect. This will be another delay, as the plan initially scheduled for August has been postponed to January.

 

The U.S. Food and Drug Administration (FDA) has announced a new standard for a ban on menthol cigarettes in 2022, aimed at addressing the illnesses and deaths initially caused by products targeting African American smokers.

 

According to data from the Centers for Disease Control and Prevention (CDC), as quoted by The Washington Post, 81% of African American smokers in the United States prefer menthol cigarettes.

 

This move comes as a series of investigations show that, despite his continued high support among black voters, Joe Biden's competition with former President Donald Trump has become challenging amidst an overall low approval rating. Trump has even gained an advantage, refusing to rule out authoritarian rule.

 

This regulatory measure has sparked a debate, with one side focusing on the potential health benefits and the other side, represented by the American Civil Liberties Union (ACLU) and other organizations, arguing that it targets a specific group of smokers and may result in black market sales.

 

Potential unintended consequences could include the shifting of production to China and the risky sale of items in vehicle trunks.

 

Last month, the Republican Party in the House of Representatives announced that they were launching an investigation into this regulatory initiative.

 

The Centers for Disease Control and Prevention (CDC) has issued a warning based on scientific research, stating that "the presence of menthol in cigarettes increases the likelihood of experimentation with smoking among adolescents and young adults, and those who start smoking will continue to do so on a regular basis.

 

Mint makes cigarettes more appealing and easier to smoke," claims the CDC. "Additionally, mint enhances the addictive effects of nicotine in the brain. In recent years, the nicotine content in mint-flavored cigarettes has increased.

 

According to data cited by the CDC, from 1980 to 2018, there were approximately 10.1 million individuals who started smoking due to menthol cigarettes, leading to an estimated 378,000 premature deaths. The agency calculated the total during this period, resulting in a "potential loss of life expectancy" of 3 million years.

 

House Majority Whip Tom Emmer told the DailyMail in a statement, "Joe Biden's decision to ban menthol cigarettes is an infuriating overreach of power and an insult to millions of Americans.

 

Furthermore, law enforcement officials previously informed the Daily Mail that the ban would result in black market smuggling, cartel and gang violence, and unregulated cigarette sales. These cigarettes may potentially contain dangerous substances, including fentanyl.

 

Furthermore, this will disproportionately affect minority communities as menthol cigarettes are primarily favored by Black and Latinx communities, accounting for over 80% of their tobacco consumption. These remarks were made by retired New York state police officer, Elliot Boyce. The Biden administration has faced criticism for simultaneously pushing for a menthol cigarette ban alongside the decriminalization of marijuana.

 

However, senior officials in the Biden administration have consistently maintained that criminal sanctions on menthol cigarettes will help Americans gradually reduce their dependence on tobacco.

 

Health and Public Services Minister Javier Beselar previously stated, "The proposed regulations will help prevent children from becoming the next generation of smokers and assist adult smokers in quitting.

 

In addition, the proposed regulations represent a significant step towards promoting health equity by substantially reducing health disparities related to tobacco," he continued.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
Product | JTI Launches Ploom AURA Teal Electric Pop in South Korea, Its First Dual-Color Edition
JTI Korea launched the Ploom AURA Teal Electric Pop limited edition in South Korea on September 1, 2026, marking the first dual-color design in the Ploom AURA range. The device combines a dark green body with teal accents and is accompanied by matching Front Panel, Back Cover and Pocket Bag accessories. The standalone device is priced at KRW 29,000, with three additional device-and-accessory bundles available. The release continues JTI Korea's use of limited colorways and interchangeable accessories to expand the Ploom AURA portfolio without introducing a new hardware platform.
Sep.03
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
IVG Parent Secures HMRC Excise Warehouse and Duty Stamp Approvals Ahead of UK Vape Tax
Acme Vape Ltd, the company behind UK vaping brand IVG, has received HM Revenue & Customs approval to operate an excise warehouse for vaping products and participate in the Vaping Duty Stamps Scheme. The UK's Vaping Products Duty will take effect on October 1, 2026, at a flat rate of £2.20 per 10ml of vaping liquid. Acme Vape Ltd says its approved warehouse in Preston will become operational under the new regime on the same date.
Regulations
Sep.18 by 2Firsts Perspectives
From Nicotine Pouches to Soft Candy Forms: China Tobacco Hubei explores adjustable-release oral nicotine products
From Nicotine Pouches to Soft Candy Forms: China Tobacco Hubei explores adjustable-release oral nicotine products
China-based China Tobacco Hubei Industrial Co., Ltd. has filed a patent application covering an oral nicotine product and its preparation method. The patent proposes a soft candy-shaped oral nicotine product containing nicotine ingredients, gelling agents, sweeteners and alkaline pH regulators. Through formulation adjustments and homogeneous or dual-layer structures, the technology aims to achieve different nicotine release profiles. The filing reflects exploration of new oral nicotine product formats and controlled nicotine delivery approaches.
Aug.06
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Says 30 PACHA Vape SKUs Tentatively Identified for FDA’s Non-Priority Enforcement Public List
Charlie’s Holdings said the U.S. Food and Drug Administration notified the company on June 23, 2026, that 30 PACHA vape SKUs with submitted PMTAs had been tentatively identified for inclusion on a planned public-facing FDA webpage. Under enforcement guidance issued by FDA in May, the webpage is intended to identify certain unauthorized products for which the agency generally does not intend to prioritize enforcement of premarket authorization requirements. Charlie’s disclosed the development alongside second-quarter revenue of $3.8 million, up 116% year over year.
Aug.25